Spero Therapeutics Announces Fourth Quarter and Full Year 2024 Operating Results and Provides a Business Update
Pre-specified interim analysis of Phase 3 PIVOT-PO clinical trial of tebipenem HBr in complicated urinary tract infection (cUTI) is expected to ...
Spero Therapeutics, Inc.: Spero Therapeutics Announces Fourth Quarter and Full Year 2024 Operating Results and Provides a Business Update
Pre-specified interim analysis of Phase 3 PIVOT-PO clinical trial of tebipenem HBr in complicated urinary tract infection (cUTI) is expected to be completed in Q2 2025Company expects to complete analy ...
AZoOptics6d
How to Interpret FTIR Results: A Beginner's Guide
Spectroscopy is a key tool for identifying chemical compounds and analyzing molecular structures. Learn how to read and ...
Indiatimes4d
Ester Industries Share Price
Ester Industries Ltd., incorporated in the year 1985, is a Small Cap company (having a market cap of Rs 1,130.20 Crore) operating in Packaging sector. Ester Industries Ltd. key Products/Revenue ...
dcceew5d
Total Phosphorus
The major use for phosphorus is as an essential nutrient for all plant and animal life, commonly as phosphate in inorganic fertiliser ... A wide variety of small molecular weight esters of phosphates ...